ly-2584702
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2008 (NCT01394003)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Ribosomal protein S6 kinase 1INHIBITOR
RPS6KB1 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1- Mol. weight
- 445.42 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545076 ↗
Also known as
- ly2584702
- ly2584702
- ly-2584702
- ly-2584702
- ly-2584702
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01372085 | Phase 1 | Jun 1, 2011 | Eli Lilly |
| NCT01241461 | Phase 1 | Nov 1, 2010 | Eli Lilly |
| NCT01115803 | Phase 1 | Mar 1, 2010 | Eli Lilly |
| NCT01394003 | Phase 1 | Nov 1, 2008 | Eli Lilly |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eli Lilly | For profit | 4 | 4 | 1 | 2008 |
1 organizations
Page 1 / 1